Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Revenio Group OyjREVXF 79 3-1 Month Momentum % is N/A% as of Sep. 01, 2026. GuruFocus rates REVXF with a GF Score™ of 79/100 and a GF Value™ of $38.41. The stock has 2 warning signs investors should review. Among 854 Medical Devices & Instruments companies, Revenio Group Oyj ranks worse than 64.87% on this metric.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-09-01), Revenio Group Oyj's 3-1 Month Momentum % is N/A%.
The industry rank for Revenio Group Oyj's 3-1 Month Momentum % or its related term are showing as below:
REVXF's 3-1 Month Momentum % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: -5.9 * Ranked among companies with meaningful 3-1 Month Momentum % only.
Revenio Group Oyj (OTCPK:REVXF) 3-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Revenio Group Oyj 3-1 Month Momentum % Related Terms
REVXF vs ABT, SYK, MDT: 3-1 Month Momentum % Comparison
For the Medical Devices subindustry, Revenio Group Oyj's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Revenio Group Oyj 3-1 Month Momentum % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Revenio Group Oyj's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Revenio Group Oyj's 3-1 Month Momentum % falls into.
Revenio Group Oyj (OTCPK:REVXF) 3-1 Month Momentum % Calculation
3-1 Month Momentum % is calculated as following:
3-1 Month Momentum %
=
( Price 1-month ago
/
Price 3-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Revenio Group Oyj (REVXF) has a 3-1 Month Momentum % of N/A% as of Sep. 01, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Revenio Group Oyj and its competitors. According to the industry distribution chart, Revenio Group Oyj ranks #554 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 64.9%.
Is Revenio Group Oyj's 3-1 Month Momentum % too high?
Revenio Group Oyj's current 3-1 Month Momentum % is N/A%. Based on the distribution chart, Revenio Group Oyj ranks #554 out of 854 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Revenio Group Oyj has a GF Score™ of 79/100, reflecting its overall financial health beyond just this single metric.
How does Revenio Group Oyj's 3-1 Month Momentum % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Revenio Group Oyj ranks #554 out of 854 companies for 3-1 Month Momentum %. This places Revenio Group Oyj in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Medical Devices & Instruments company?
A good 3-1 Month Momentum % depends on the Medical Devices & Instruments industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Revenio Group Oyj and its competitors. Revenio Group Oyj's current 3-1 Month Momentum % is N/A%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Revenio Group Oyj stock overvalued right now?
Revenio Group Oyj (REVXF) has a current 3-1 Month Momentum % of N/A%. The stock's GF Value™ is $38.41, compared to a current price of $16.41 — trading 57.3% below its estimated fair value. The current 3-1 Month Momentum % is N/A%. Revenio Group Oyj's overall GF Score™ is 79/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Revenio Group Oyj (REVXF), the current 3-1 Month Momentum % is N/A% as of Sep. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Revenio Group Oyj (REVXF) Overvalued in 2026?
Based on GuruFocus' analysis, Revenio Group Oyj stock appears to be undervalued.
The current stock price of $16.41 is trading 57.3% below its estimated GF Value™ of $38.41.
Key valuation signals for REVXF:
3-1 Month Momentum %: N/A%
GF Value™: $38.41 vs. price of $16.41 (57.3% below fair value)
No single metric tells the full story. See the REVXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Revenio Group Oyj is a Finnish health technology company. It develops and commercializes effective, easy-to-use health tech-related screening devices for detecting diseases of public health significance. Its ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), and perimeter and fundus imaging devices under the iCare brand. Its eye care software platform, Oculo, offers clinical communication, telehealth, remote patient monitoring, and data analytics capabilities. The company generates the majority of its revenue from the United States.
79GF Score
Get the complete analysis for REVXF
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
REVXF has been successfully added to your 
